VIENNA—Latest research on breast cancer prevention was reported at the 20125 St Gallen breast cancer conference in a session concluded by Jack Cuzick, PhD, Director of the Wolfson Institute of Preventive Medicine and Head of the Centre for Cancer Prevention at Queen Mary, University of London. Oncology Times reporter Sarah Maxwell began by asking him about the IBIS I and II studies—using drugs affecting the estrogen receptor—and about IBIS III using aromatase inhibitor, bisphosphonate and metformin for primary prevention.
You may also like...
Esophageal Cancer Prevented By Proton Pump Inhibitor Plus Aspirin 15 Aug, 2018 Building Health For All Capacity In Tanzania 30 Mar, 2012 Orteronel shows no survival advantage in metastatic castration-resistant prostate cancer: phase III randomized study finds 6 Feb, 2014 Young Women with HER2+ Early Breast Cancer Better with Mastectomy 24 Aug, 2016
- Previous story Adjuvant Chemotherapy Extends Life in Locally Advanced Bladder Cancer
- Next story New Strategies for Preventing ER-Negative Breast Cancer
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014